Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masayuki Shirasawa

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Japanese Journal of Clinical Oncology|October 12, 2023
Biomarkers of immunotherapy for non-small cell lung cancerMasayuki Shirasawa, Tatsuya Yoshida, Yuichiro Ohe
International Journal of Clinical Oncology|January 17, 2025
Analysis of lung cancer incidence, mortality trends, and smoking rates in Japan:1975-2022 with insights on the impact of COVID-19Hiroki Yamamoto, Masayuki Shirasawa, Katsuhiko Naoki
Thoracic Cancer|October 21, 2020
Clinical outcomes of pembrolizumab therapy in advanced-NSCLC patients with poor performance status (≥3) and high PD-L1 expression (TPS ≥50%): A case seriesRyoko Inaba-Higashiyama, Tatsuya Yoshida, Hitomi Jo, et al.
Respiratory Medicine Case Reports|March 19, 2025
Severe denosumab-induced hypocalcemia requiring long-term intensified medication in a patient with <i>EGFR</i>-mutant lung cancer and diffuse osteoblastic bone metastasesMasayuki Mori, Masayuki Shirasawa, Akihito Oguri, et al.
BMC Cancer|February 28, 2019
Efficacy and risk of cytotoxic chemotherapy in extensive disease-small cell lung cancer patients with interstitial pneumoniaMasayuki Shirasawa, Tomoya Fukui, Seiichiro Kusuhara, et al.
Respiratory Medicine Case Reports|August 19, 2016
Endobronchial involvement of mantle cell lymphoma: A case reportKen Katono, Masayuki Shirasawa, Shinya Harada, et al.
Oncology|May 29, 2016
Smoking History as a Predictor of Pemetrexed Monotherapy in Patients with Non-Squamous Non-Small Cell Lung CancerSatoshi Igawa, Jiichiro Sasaki, Sakiko Otani, et al.
Lung Cancer (Amsterdam, Netherlands)|August 28, 2016
Successful oral desensitization against skin rash induced by alectinib in a patient with anaplastic lymphoma kinase-positive lung adenocarcinoma: A case reportMasayuki Shirasawa, Masaru Kubotaa, Shinya Harada, et al.
Molecular and Clinical Oncology|January 21, 2017
Interstitial pneumonia following administration of pegfilgrastim during carboplatin and etoposide chemotherapy for small-cell lung cancerMasayuki Shirasawa, Yoshiro Nakahara, Hideyuki Niwa, et al.
NPJ Precision Oncology|January 15, 2025
Diversity of TCR repertoire predicts recurrence after CRT followed by durvalumab in patients with NSCLCMasayuki Shirasawa, Tatsuya Yoshida, Takaji Matsutani, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Japanese Journal of Clinical Oncology|October 12, 2023
Biomarkers of immunotherapy for non-small cell lung cancerMasayuki Shirasawa, Tatsuya Yoshida, Yuichiro Ohe
International Journal of Clinical Oncology|January 17, 2025
Analysis of lung cancer incidence, mortality trends, and smoking rates in Japan:1975-2022 with insights on the impact of COVID-19Hiroki Yamamoto, Masayuki Shirasawa, Katsuhiko Naoki
Thoracic Cancer|October 21, 2020
Clinical outcomes of pembrolizumab therapy in advanced-NSCLC patients with poor performance status (≥3) and high PD-L1 expression (TPS ≥50%): A case seriesRyoko Inaba-Higashiyama, Tatsuya Yoshida, Hitomi Jo, et al.
Respiratory Medicine Case Reports|March 19, 2025
Severe denosumab-induced hypocalcemia requiring long-term intensified medication in a patient with <i>EGFR</i>-mutant lung cancer and diffuse osteoblastic bone metastasesMasayuki Mori, Masayuki Shirasawa, Akihito Oguri, et al.
BMC Cancer|February 28, 2019
Efficacy and risk of cytotoxic chemotherapy in extensive disease-small cell lung cancer patients with interstitial pneumoniaMasayuki Shirasawa, Tomoya Fukui, Seiichiro Kusuhara, et al.
Respiratory Medicine Case Reports|August 19, 2016
Endobronchial involvement of mantle cell lymphoma: A case reportKen Katono, Masayuki Shirasawa, Shinya Harada, et al.
Oncology|May 29, 2016
Smoking History as a Predictor of Pemetrexed Monotherapy in Patients with Non-Squamous Non-Small Cell Lung CancerSatoshi Igawa, Jiichiro Sasaki, Sakiko Otani, et al.
Lung Cancer (Amsterdam, Netherlands)|August 28, 2016
Successful oral desensitization against skin rash induced by alectinib in a patient with anaplastic lymphoma kinase-positive lung adenocarcinoma: A case reportMasayuki Shirasawa, Masaru Kubotaa, Shinya Harada, et al.
Molecular and Clinical Oncology|January 21, 2017
Interstitial pneumonia following administration of pegfilgrastim during carboplatin and etoposide chemotherapy for small-cell lung cancerMasayuki Shirasawa, Yoshiro Nakahara, Hideyuki Niwa, et al.
NPJ Precision Oncology|January 15, 2025
Diversity of TCR repertoire predicts recurrence after CRT followed by durvalumab in patients with NSCLCMasayuki Shirasawa, Tatsuya Yoshida, Takaji Matsutani, et al.
Pageof 4